The Magazine for Sleep Professionals
Tuesday, June 9, 2026
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to treat obstructive sleep apnea (OSA) and related disorders, announced positive topline results from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration. The topline results were positive for the company’s lead candidate for […]
We all know someone who is “supposed” to wear their CPAP machine but doesn’t. The one who went through the process of having a custom dental appliance made but doesn’t bother to wear it. The one who continues to suffer from sleep deprivation because even when they did what they […]
By Nathan Costiuc, MSN, APRN, FNP-BC Inspiratory muscle training, also known as IMT, is an emerging area of research in the treatment of Obstructive Sleep Apnea (OSA). And although that research is in its early stages, IMT has shown promise as an effective way to improve OSA as an adjuvant […]
Incannex Healthcare Limited (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, is pleased to announce that it has completed analysis of data from the Phase 2 proof-of-concept clinical trial investigating IHL-42X for treatment of obstructive sleep […]
Positioned at the forefront of helping people with obstructive sleep apnea (OSA) improve their health and quality of life, AR Medical Technologies launches MaskFit AR. Powered by artificial intelligence and machine learning, MaskFit AR overcomes a 30-year problem of improper patient mask fitment for people who use CPAP or BiPAPTM to […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating AD109 as a treatment for mild to moderate OSA. If successful, AD109 could offer an […]
Introduction Sleep apnea, with an estimated incidence between three and seven percent in the general population, is a common disorder.1 Currently, either an at-home sleep test or overnight polysomnographic test is necessary to diagnose sleep apnea. Both of these evaluations are at times cumbersome. Consequently, patients may be unwilling to […]
Older adults with undiagnosed obstructive sleep apnea seek more health care, according to a study published in the January issue of the Journal of Clinical Sleep Medicine. The study examined the impact of untreated sleep apnea on health care utilization and costs among Medicare beneficiaries. The authors reviewed a sample of Medicare […]
By Matthew Anastasi, BS, RST, RPSGT Located in the tiny village of Merida, Venezuela is Heladería Coromoto, an ice cream parlor, known for offering a Guinness Record for most flavors of ice cream in the world (860 varieties). Despite our sometimes homogeneous view of the condition, sleep-disordered breathing (SDB) has […]
A research team led by the University of Minnesota Morris found that a trucking firm that mandated treatment for its drivers with obstructive sleep apnea (OSA) saved significantly on non-OSA-program medical insurance costs. Despite evidence that untreated OSA is associated with significantly higher rates of serious preventable truck crashes, the U.S. Department […]
